Global Antiemetic Drugs Market Research Report 2024(Status and Outlook)

Global Antiemetic Drugs Market Research Report 2024(Status and Outlook)



Report Overview:

An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.

The Global Antiemetic Drugs Market Size was estimated at USD 4994.03 million in 2023 and is projected to reach USD 6503.53 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.

This report provides a deep insight into the global Antiemetic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiemetic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiemetic Drugs market in any manner.

Global Antiemetic Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline

Johnson & Johnson

Pfizer

Sanofi

Abbott

Bristol-Myers Squibb

Cipla

Eisai

Eli Lilly

Glenmark

Helsinn Healthcare

Heron Therapeutics

IPCA Laboratories

Lupin

Merck

Novartis

RedHill

Sun Pharmaceutical Industries

Takeda Pharmaceutical

Market Segmentation (by Type)

Dopamine Antagonist

5-HT-3 Receptor Antagonist

NK1 Receptor Antagonist

Cannabinoid Receptor Antagonist

Market Segmentation (by Application)

Chemotherapy

Gastroenteritis

Surgery

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antiemetic Drugs Market

Overview of the regional outlook of the Antiemetic Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiemetic Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antiemetic Drugs
1.2 Key Market Segments
1.2.1 Antiemetic Drugs Segment by Type
1.2.2 Antiemetic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antiemetic Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Antiemetic Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antiemetic Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antiemetic Drugs Market Competitive Landscape
3.1 Global Antiemetic Drugs Sales by Manufacturers (2019-2024)
3.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiemetic Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiemetic Drugs Sales Sites, Area Served, Product Type
3.6 Antiemetic Drugs Market Competitive Situation and Trends
3.6.1 Antiemetic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiemetic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antiemetic Drugs Industry Chain Analysis
4.1 Antiemetic Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antiemetic Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antiemetic Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiemetic Drugs Sales Market Share by Type (2019-2024)
6.3 Global Antiemetic Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Antiemetic Drugs Price by Type (2019-2024)
7 Antiemetic Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiemetic Drugs Market Sales by Application (2019-2024)
7.3 Global Antiemetic Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
8 Antiemetic Drugs Market Segmentation by Region
8.1 Global Antiemetic Drugs Sales by Region
8.1.1 Global Antiemetic Drugs Sales by Region
8.1.2 Global Antiemetic Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Antiemetic Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiemetic Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiemetic Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiemetic Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiemetic Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Antiemetic Drugs Basic Information
9.1.2 GlaxoSmithKline Antiemetic Drugs Product Overview
9.1.3 GlaxoSmithKline Antiemetic Drugs Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Antiemetic Drugs SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Antiemetic Drugs Basic Information
9.2.2 Johnson and Johnson Antiemetic Drugs Product Overview
9.2.3 Johnson and Johnson Antiemetic Drugs Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Antiemetic Drugs SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Pfizer
9.3.1 Pfizer Antiemetic Drugs Basic Information
9.3.2 Pfizer Antiemetic Drugs Product Overview
9.3.3 Pfizer Antiemetic Drugs Product Market Performance
9.3.4 Pfizer Antiemetic Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi Antiemetic Drugs Basic Information
9.4.2 Sanofi Antiemetic Drugs Product Overview
9.4.3 Sanofi Antiemetic Drugs Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Abbott
9.5.1 Abbott Antiemetic Drugs Basic Information
9.5.2 Abbott Antiemetic Drugs Product Overview
9.5.3 Abbott Antiemetic Drugs Product Market Performance
9.5.4 Abbott Business Overview
9.5.5 Abbott Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Antiemetic Drugs Basic Information
9.6.2 Bristol-Myers Squibb Antiemetic Drugs Product Overview
9.6.3 Bristol-Myers Squibb Antiemetic Drugs Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Cipla
9.7.1 Cipla Antiemetic Drugs Basic Information
9.7.2 Cipla Antiemetic Drugs Product Overview
9.7.3 Cipla Antiemetic Drugs Product Market Performance
9.7.4 Cipla Business Overview
9.7.5 Cipla Recent Developments
9.8 Eisai
9.8.1 Eisai Antiemetic Drugs Basic Information
9.8.2 Eisai Antiemetic Drugs Product Overview
9.8.3 Eisai Antiemetic Drugs Product Market Performance
9.8.4 Eisai Business Overview
9.8.5 Eisai Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Antiemetic Drugs Basic Information
9.9.2 Eli Lilly Antiemetic Drugs Product Overview
9.9.3 Eli Lilly Antiemetic Drugs Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Glenmark
9.10.1 Glenmark Antiemetic Drugs Basic Information
9.10.2 Glenmark Antiemetic Drugs Product Overview
9.10.3 Glenmark Antiemetic Drugs Product Market Performance
9.10.4 Glenmark Business Overview
9.10.5 Glenmark Recent Developments
9.11 Helsinn Healthcare
9.11.1 Helsinn Healthcare Antiemetic Drugs Basic Information
9.11.2 Helsinn Healthcare Antiemetic Drugs Product Overview
9.11.3 Helsinn Healthcare Antiemetic Drugs Product Market Performance
9.11.4 Helsinn Healthcare Business Overview
9.11.5 Helsinn Healthcare Recent Developments
9.12 Heron Therapeutics
9.12.1 Heron Therapeutics Antiemetic Drugs Basic Information
9.12.2 Heron Therapeutics Antiemetic Drugs Product Overview
9.12.3 Heron Therapeutics Antiemetic Drugs Product Market Performance
9.12.4 Heron Therapeutics Business Overview
9.12.5 Heron Therapeutics Recent Developments
9.13 IPCA Laboratories
9.13.1 IPCA Laboratories Antiemetic Drugs Basic Information
9.13.2 IPCA Laboratories Antiemetic Drugs Product Overview
9.13.3 IPCA Laboratories Antiemetic Drugs Product Market Performance
9.13.4 IPCA Laboratories Business Overview
9.13.5 IPCA Laboratories Recent Developments
9.14 Lupin
9.14.1 Lupin Antiemetic Drugs Basic Information
9.14.2 Lupin Antiemetic Drugs Product Overview
9.14.3 Lupin Antiemetic Drugs Product Market Performance
9.14.4 Lupin Business Overview
9.14.5 Lupin Recent Developments
9.15 Merck
9.15.1 Merck Antiemetic Drugs Basic Information
9.15.2 Merck Antiemetic Drugs Product Overview
9.15.3 Merck Antiemetic Drugs Product Market Performance
9.15.4 Merck Business Overview
9.15.5 Merck Recent Developments
9.16 Novartis
9.16.1 Novartis Antiemetic Drugs Basic Information
9.16.2 Novartis Antiemetic Drugs Product Overview
9.16.3 Novartis Antiemetic Drugs Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 RedHill
9.17.1 RedHill Antiemetic Drugs Basic Information
9.17.2 RedHill Antiemetic Drugs Product Overview
9.17.3 RedHill Antiemetic Drugs Product Market Performance
9.17.4 RedHill Business Overview
9.17.5 RedHill Recent Developments
9.18 Sun Pharmaceutical Industries
9.18.1 Sun Pharmaceutical Industries Antiemetic Drugs Basic Information
9.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Product Overview
9.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Product Market Performance
9.18.4 Sun Pharmaceutical Industries Business Overview
9.18.5 Sun Pharmaceutical Industries Recent Developments
9.19 Takeda Pharmaceutical
9.19.1 Takeda Pharmaceutical Antiemetic Drugs Basic Information
9.19.2 Takeda Pharmaceutical Antiemetic Drugs Product Overview
9.19.3 Takeda Pharmaceutical Antiemetic Drugs Product Market Performance
9.19.4 Takeda Pharmaceutical Business Overview
9.19.5 Takeda Pharmaceutical Recent Developments
10 Antiemetic Drugs Market Forecast by Region
10.1 Global Antiemetic Drugs Market Size Forecast
10.2 Global Antiemetic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antiemetic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Antiemetic Drugs Market Size Forecast by Region
10.2.4 South America Antiemetic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antiemetic Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antiemetic Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antiemetic Drugs by Type (2025-2030)
11.1.2 Global Antiemetic Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antiemetic Drugs by Type (2025-2030)
11.2 Global Antiemetic Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Antiemetic Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Antiemetic Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings